Blocking NF-kB proteasome inhibitors inhibits MM cell adherence to the BM stromal cells, reducing MM cell growth and VEGF-2 and FGF-2 secretion [11,12,15,16,20]. The gene discussed is FGF2; the disease is Miyoshi myopathy.